Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

Delayed Quote. Delayed  - 08/26 10:00:00 pm
96.22 USD   +1.32%
08/25 BIOMARIN PHARMA : Forbes Ranks BioMarin 10th Most Innovative Company..
08/24 Forbes Ranks BioMarin 10th Most Innovative Company in the World
08/22 NASDAQ 100 MOVE : Viab, incy
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/22/2016 08/23/2016 08/24/2016 08/25/2016 08/26/2016 Date
98.17(c) 99.43(c) 95.13(c) 94.97(c) 96.22(c) Last
3 985 359 1 696 076 2 482 655 1 633 078 1 287 516 Volume
+6.72% +1.28% -4.32% -0.17% +1.32% Change
More quotes
Financials ($)
Sales 2016 1 129 M
EBIT 2016 -764 M
Net income 2016 -607 M
Debt 2016 218 M
Yield 2016 -
Sales 2017 1 343 M
EBIT 2017 -159 M
Net income 2017 -200 M
Debt 2017 219 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales2016 14,8x
EV / Sales2017 12,4x
Capitalization 16 433 M
More Financials
Company
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.It operates its business through one segment, the biopharmaceutical development and commercialization segment.Its company's products include... 
Sector
Pharmaceuticals
Calendar
10/20Earnings Release
More about the company
Surperformance© ratings of BioMarin Pharmaceutical In
Trading Rating : Investor Rating :
More Ratings
Latest news on BIOMARIN PHARMACEUTICAL IN
08/25 BIOMARIN PHARMACEUTICAL : Forbes Ranks BioMarin 10th Most Innovative Company in ..
08/24 Forbes Ranks BioMarin 10th Most Innovative Company in the World
08/22 NASDAQ 100 MOVERS : Viab, incy
08/11 BIOMARIN PHARMACEUTICAL INC : Entry into a Material Definitive Agreement, Other ..
08/09 BioMarin Announces Pricing of Public Offering of Common Stock
08/08 BioMarin Announces Public Offering of Common Stock
08/08 BIOMARIN PHARMACEUTICAL : Management's Discussion and Analysis of Financial Cond..
08/08 BIOMARIN PHARMACEUTICAL : Financial Statements and Exhibits (form 8-K/A)
08/04 BIOMARIN PHARMACEUTICAL : reports 2Q loss
08/04 BIOMARIN PHARMACEUTICAL INC : Results of Operations and Financial Condition, Fin..
More news
Sector news : Generic Pharmaceuticals
08/27 Stada shareholder AOC pushes through board reshuffle
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
08/26DJALERE : Sues Abbott to Force Merger -- 2nd Update
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
08/25 Mallinckrodt's Synacthen Depot Fast Track'd for Duchenne muscular dystrophy
08/23 Who's Next After Medivation?
08/22 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2016 Update
08/11 SAREPTA : The Competition Is At The Gate
08/10 FDA accepts Marathon Pharma's NDAs for Duchenne candidate deflazacort under a..
Advertisement
Chart BIOMARIN PHARMACEUTICAL IN
Duration : Period :
BioMarin Pharmaceutical In Technical Analysis Chart | BMRN | US09061G1013 | 4-Traders
Full-screen chart
Technical analysis trends BIOMARIN PHARMACE...
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 119 $
Spread / Average Target 24%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jean-Jacques Bienaimé Chairman & Chief Executive Officer
Daniel K. Spiegelman Chief Financial Officer & Executive Vice President
Henry J. Fuchs Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux Chief Information Officer & Vice President
Pierre Lapalme Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..-8.15%16 433
SUN PHARMACEUTICAL IND..-7.86%27 078
OTSUKA HOLDINGS CO LTD4.52%24 813
ONO PHARMACEUTICAL CO...-37.26%15 679
ASPEN PHARMACARE HOLDI..17.99%11 642
TAISHO PHARMACEUTICAL ..13.33%8 504
More Results